These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9871734)
1. Synthesis of tools for target identification of the anti-apoptotic compound CGP 3466; Part I. Zimmermann K; Roggo S; Kragten E; Fürst P; Waldmeier P Bioorg Med Chem Lett; 1998 May; 8(10):1195-200. PubMed ID: 9871734 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of phenylamino-substituted 6,11-dihydro-dibenzo[b,e]oxepin-11-ones and dibenzo[a,d]cycloheptan-5-ones: novel p38 MAP kinase inhibitors. Laufer SA; Ahrens GM; Karcher SC; Hering JS; Niess R J Med Chem; 2006 Dec; 49(26):7912-5. PubMed ID: 17181176 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and SAR of phenylamino-substituted 5,11-dihydro-dibenzo[a,d]cyclohepten-10-ones and 11H-dibenzo[b,f]oxepin-10-ones as p38 MAP kinase inhibitors. Dorn A; Schattel V; Laufer S Bioorg Med Chem Lett; 2010 May; 20(10):3074-7. PubMed ID: 20418099 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2-N,N-dimethylaminomethyl-2,3,3a,12b-tetrahydrodibenzo-[b,f]furo[2,3-d]oxepin derivatives as potential anxiolytic agents. Trabanco AA; Alonso JM; Andrés JI; Cid JM; Fernández J; Iturrino L; Megens A Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):262-5. PubMed ID: 14758015 [TBL] [Abstract][Full Text] [Related]
8. Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson's disease. Jenner P Neurology; 2004 Oct; 63(7 Suppl 2):S13-22. PubMed ID: 15477581 [No Abstract] [Full Text] [Related]
9. (-)Deprenyl-N-oxide, a (-)deprenyl metabolite, is cytoprotective after hypoxic injury in PC12 cells, or after transient brain ischemia in gerbils. Szilágyi G; Simon L; Wappler E; Magyar K; Nagy Z J Neurol Sci; 2009 Aug; 283(1-2):182-6. PubMed ID: 19332347 [TBL] [Abstract][Full Text] [Related]
10. N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change. Shin EJ; Nam Y; Lee JW; Nguyen PT; Yoo JE; Tran TV; Jeong JH; Jang CG; Oh YJ; Youdim MBH; Lee PH; Nabeshima T; Kim HC Mol Neurobiol; 2016 Nov; 53(9):6251-6269. PubMed ID: 26563498 [TBL] [Abstract][Full Text] [Related]
11. New short strategy for the synthesis of the dibenz[b,f]oxepin scaffold. Moreno DR; Giorgi G; Salas CO; Tapia RA Molecules; 2013 Nov; 18(12):14797-806. PubMed ID: 24352054 [TBL] [Abstract][Full Text] [Related]
12. The pharmacology of selegiline. Magyar K Int Rev Neurobiol; 2011; 100():65-84. PubMed ID: 21971003 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective actions of Selegiline in inhibiting 1-methyl, 4-phenyl, pyridinium ion (MPP+)-induced apoptosis in SK-N-SH neurons. Sharma SK; Carlson EC; Ebadi M J Neurocytol; 2003 May; 32(4):329-43. PubMed ID: 14724376 [TBL] [Abstract][Full Text] [Related]
14. Deprenyl: from chemical synthesis to neuroprotection. Magyar K; Pálfi M; Jenei V; Szöko E J Neural Transm Suppl; 2006; (71):143-56. PubMed ID: 17447425 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of new ionone derivatives as potential neuroprotective agents in cerebral ischemia. Srivastava AK; Dohare P; Ray M; Panda G Eur J Med Chem; 2010 May; 45(5):1964-71. PubMed ID: 20170988 [TBL] [Abstract][Full Text] [Related]
16. Different neurorescue profiles of selegiline and p-fluoro-selegiline in gerbils. Erdö F; Baranyi A; Takács J; Arányi P Neuroreport; 2000 Aug; 11(11):2597-600. PubMed ID: 10943729 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of pyrimido[4,5-c]azepine- and pyrimido[4,5-c]oxepine-based γ-secretase modulators. Wu YJ; Zhang Y; Toyn JH; Macor JE; Thompson LA Bioorg Med Chem Lett; 2016 Mar; 26(6):1554-1557. PubMed ID: 26898338 [TBL] [Abstract][Full Text] [Related]
18. The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity. Alonso De Diego SA; Gutiérrez-Rodríguez M; Pérez de Vega MJ; González-Muñiz R; Herranz R; Martín-Martínez M; Cenarruzabeitia E; Frechilla D; Del Río J; Jimeno ML; García-López MT Bioorg Med Chem Lett; 2006 Jul; 16(13):3396-400. PubMed ID: 16650992 [TBL] [Abstract][Full Text] [Related]
19. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Semkova I; Wolz P; Schilling M; Krieglstein J Eur J Pharmacol; 1996 Nov; 315(1):19-30. PubMed ID: 8960860 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship studies of (E)-3,4-dihydroxystyryl alkyl sulfones as novel neuroprotective agents based on improved antioxidant, anti-inflammatory activities and BBB permeability. Chen Y; Wu B; Hao Y; Liu Y; Zhang Z; Tian C; Ning X; Guo Y; Liu J; Wang X Eur J Med Chem; 2019 Jun; 171():420-433. PubMed ID: 30928712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]